CRON stock is having a tough day as shares of Cronos Group Inc. (TSX:CRON) (NASDAQ:CRON) tumbled despite the company posting improved revenue and net loss for the fiscal first quarter.
Improved ResultsThe company reported a 15% increase in net revenue in the Q1 from $2.9 million CAD a year ago to $6.5 million CAD, which was a result of the increase in sales of CBD oil and dry flower. Net income for the quarter was $427,812 CAD and EPS of $0.48, which is an improvement from a year ago loss of $0.01 per share.
...Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.